# OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade Gliomas

> **NCT01052363** · PHASE1 · WITHDRAWN · sponsor: **West Virginia University**

## Conditions studied

- Central Nervous System Tumors

## Interventions

- **DRUG:** Bevacizumab, CA4P

## Key facts

- **NCT ID:** NCT01052363
- **Lead sponsor:** West Virginia University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No funding
- **Last updated:** 2017-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01052363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01052363, "OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade Gliomas". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01052363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*